Xenpozyme

Active Ingredient(s): Olipudase Alfa-rpcp
FDA Approved: * August 31, 2022
Pharm Company: * GENZYME CORP
Category: Enzymes
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xenpozyme 20 mg/5.1ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 58468-0050
Labeler:
Genzyme Corporation
Xenpozyme 4 mg/1.1ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 58468-0051
Labeler:
Genzyme Corporation